(1)        Hinther, A.; Abdel-Rahman, O.; Cheung, W. Y.; Quan, M. L.; Dort, J. C. Chronic Postoperative Opioid Use: A Systematic Review. World J. Surg. 2019, 43 (9), 2164–2174.

(2)        Saloner, B.; McGinty, E. E.; Beletsky, L.; Bluthenthal, R.; Beyrer, C.; Botticelli, M.; Sherman, S. G. A Public Health Strategy for the Opioid Crisis. Public Health Rep. 2018, 133 (1_suppl), 24S-34S.

(3)        US department of Agriculture. Opioid Misuse in Rural Americal

(4)        Al-Hasani, R.; Bruchas, M. R. Molecular Mechanisms of Opioid Receptor-Dependent Signaling and Behavior: Anesthesiology 2011, 1.

(5)        Beck, T. C.; Hapstack, M. A.; Beck, K. R.; Dix, T. A. Therapeutic Potential of Kappa Opioid Agonists. Pharmaceuticals 2019, 12 (2), 95.

(6)        Nation Institute on Drug Abuse. Opioid Overdose Crisis

(7)        Ballantyne, J. C.; Murinova, N.; Krashin, D. L. Opioid Guidelines Are a Necessary Response to the Opioid Crisis. Clin. Pharmacol. Ther. 2018, 103 (6), 946–949.

(8)        Vowles, K. E.; McEntee, M. L.; Julnes, P. S.; Frohe, T.; Ney, J. P.; van der Goes, D. N. Rates of Opioid Misuse, Abuse, and Addiction in Chronic Pain: A Systematic Review and Data Synthesis. PAIN 2015, 156 (4), 569–576.

(9)        National institute on Drug Abuse. Overdose Death Rates

(10)      Jones, C. M. Heroin Use and Heroin Use Risk Behaviors among Nonmedical Users of Prescription Opioid Pain Relievers – United States, 2002–2004 and 2008–2010. Drug Alcohol Depend. 2013, 132 (1–2), 95–100.

(11)      Yam, M.; Loh, Y.; Tan, C.; Khadijah Adam, S.; Abdul Manan, N.; Basir, R. General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation. Int. J. Mol. Sci. 2018, 19 (8), 2164.

(12)      Goldberg, J. S. Chronic Opioid Therapy and Opioid Tolerance: A New Hypothesis. Pain Res. Treat. 2013, 2013, 1–6.

(13)      Sudhof, T. C. Calcium Control of Neurotransmitter Release. Cold Spring Harb. Perspect. Biol. 2012, 4 (1), a011353–a011353.

(14)      Georg Bernhard Landwehrmeyer. Expression of Mu, Kappa, and Delta Opioid Receptor Messenger RNA in the Human CNS: A 33P in Situ Hybridization Study. Neuroscience 1999, 88 (4), 1093–1135.

(15)      Valentino, R. J.; Volkow, N. D. Untangling the Complexity of Opioid Receptor Function. Neuropsychopharmacology 2018, 43 (13), 2514–2520.

(16)      Bruijnzeel, A. W. Kappa-Opioid Receptor Signaling and Brain Reward Function. Brain Res. Rev. 2009, 62 (1), 127–146.

(17)      Escobar, A. P.; González, M. P.; Meza, R. C.; Noches, V.; Henny, P.; Gysling, K.; España, R. A.; Fuentealba, J. A.; Andrés, M. E. Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats. Int. J. Neuropsychopharmacol. 2017, 20 (8), 660–669.

(18)      Ehrich, J. M.; Messinger, D. I.; Knakal, C. R.; Kuhar, J. R.; Schattauer, S. S.; Bruchas, M. R.; Zweifel, L. S.; Kieffer, B. L.; Phillips, P. E. M.; Chavkin, C. Kappa Opioid Receptor-Induced Aversion Requires P38 MAPK Activation in VTA Dopamine Neurons. J. Neurosci. 2015, 35 (37), 12917–12931.

(19)      Zhao, X.; Jones, A.; Olson, K. R.; Peng, K.; Wehrman, T.; Park, A.; Mallari, R.; Nebalasca, D.; Young, S. W.; Xiao, S.-H. A Homogeneous Enzyme Fragment Complementation-Based β-Arrestin Translocation Assay for High-Throughput Screening of G-Protein-Coupled Receptors. J. Biomol. Screen. 2008, 13 (8), 737–747.

(20)      Hughes, Jr., F. M. Development of a Peptide-Derived Orally-Active Kappa-Opioid Receptor Agonist Targeting Peripheral Pain. Open Med. Chem. J. 2013, 7 (1), 16–22.

(21)      Beck, T. C.; Reichel, C. M.; Helke, K. L.; Bhadsavle, S. S.; Dix, T. A. Non-Addictive Orally-Active Kappa Opioid Agonists for the Treatment of Peripheral Pain in Rats. Eur. J. Pharmacol. 2019, 856, 172396.

(22)      Bechara, E. J. H.; Stevani, C. V. Brazilian Bioluminescent Beetles: Reflections on Catching Glimpses of Light in the Atlantic Forest and Cerrado. An. Acad. Bras. Ciênc. 2018, 90 (1 suppl 1), 663–679.

(23)      Marques, S. M.; Esteves da Silva, J. C. G. Firefly Bioluminescence: A Mechanistic Approach of Luciferase Catalyzed Reactions. IUBMB Life 2009, 61 (1), 6–17.

(24)      Yue, L.; Liu, Y.-J.; Fang, W.-H. Mechanistic Insight into the Chemiluminescent Decomposition of Firefly Dioxetanone. J. Am. Chem. Soc. 2012, 134 (28), 11632–11639.

(25)      Eans, S. O.; Ganno, M. L.; Mizrachi, E.; Houghten, R. A.; Dooley, C. T.; McLaughlin, J. P.; Nefzi, A. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors. J. Med. Chem. 2015, 58 (12), 4905–4917.